Display Settings:

Format

Send to:

Choose Destination

    Cytometry A. 2008 Jul;73(7):637-42.

    A long-term flow cytometry assay to analyze the role of specific genes of Drosophila melanogaster S2 cells in surviving genotoxic stress.

    Yi X, Lemstra W, Vos MJ, Shang Y, Kampinga HH, Su TT, Sibon OC.

    Department of Radiation and Stress Cell Biology, Division of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

    Drosophila S2 cells are easy to manipulate and culture and are a versatile model system for high-throughput screens such as genome-wide siRNA screens to find genes involved in stress or therapy resistance or for screening through large compound libraries to identify cytotoxins. Clonogenic assays are considered the gold-standard to investigate the cytotoxicity of specific treatments or to compare the sensitivity of various cell types for a specific treatment. However, this assay cannot be used for Drosophila S2 cells as they are virtually unable to grow in distinct colonies. We designed a novel fluorescence-based flow cytometry assay to study long-term proliferation of S2 cells under various conditions and in the presence of specific gene products or after downregulation of specific gene products. Here we validate this assay and we used this novel method to investigate the role of checkpoint genes grapes/Dchk1 and DmChk2 in cell survival responses. Our data demonstrate that Grapes/Dchk1 but not DmChk2 is required to survive hydroxyurea. Our assay will be of use to investigate the long-term effects of various treatments in S2 cells and to evaluate the role of specific proteins therein. (c) 2008 International Society for Advancement of Cytometry

    PMID: 18496848 [PubMed - indexed for MEDLINE]

    PMCID: 2579795

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Hydroxyurea (Droxia®, Hydrea®)

      Your doctor has ordered hydroxyurea to help treat your illness. Hydroxyurea comes as a capsule to take by mouth.